IQVIA Holdings (IQV) Statistics

IQVIA Holdings Inc, also known as IQV, is a leading global provider of advanced analytics and technology solutions to the healthcare industry. The company offers a wide range of services, including strategic consulting, data management, clinical trial support, and real-world evidence solutions. With a strong presence in more than 100 countries, IQVIA serves a diverse customer base that includes pharmaceutical companies, biotech firms, medical device manufacturers, and government agencies. As of December 31, 2020, the company had approximately 70,000 employees worldwide.

When it comes to valuation metrics, IQVIA Holdings Inc has a market capitalization of around $44 billion and a price-to-earnings ratio of approximately 29. The company's stock has performed well in recent years, consistently outperforming the broader sector. Over the past five years, IQVIA's stock has generated a total return of over 150%, compared to a sector average of around 80%. This strong performance can be attributed to IQVIA's robust fundamentals, including its solid revenue growth and healthy profit margins. In terms of fundamentals, the company has a revenue per share of approximately $55 and a gross profit margin of around 44%. Moreover, IQVIA has managed its debt levels prudently, with a total debt of around $10 billion and an enterprise value to EBITDA ratio of approximately 12.